Skip to main content
Top

Supportive Care in Cancer

Issue 2/2001

Content (11 Articles)

Editorial

Opioids in cancer pain — which one is best?

Clive H. Wilder-Smith

Review Article

Hydromorphone: pharmacology and clinical applications in cancer patients

Nabeel Sarhill, Declan Walsh, Kristine A. Nelson

Original Article

Cancer patients hospitalised for palliative reasons. Symptoms and needs presented at a university hospital

Eva Åstradsson, Lena Granath, Per-Anders Heedman, Hans Starkhammar

Original Paper

Superior vena cava obstruction: is stenting necessary?

P.-Y. Marcy, N. Magné, F. Bentolila, J. Drouillard, J.-N. Bruneton, B. Descamps

Original article

Prevention of vinorelbine phlebitis with cimetidine

M. Vassilomanolakis, G. Koumakis, V. Barbounis, G. Orphanos, A. Efremidis

Original Article

The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up

Linda E. Carlson, Zenovia Ursuliak, Eileen Goodey, Maureen Angen, Michael Speca

Short Communication

Methadone in treatment of tenesmus not responding to morphine escalation

Sebastiano Mercadante, Fabio Fulfaro, Marcella Dabbene

Short Communication

Docetaxel extravasation

P. Berghammer, R. Pöhnl, M. Baur, C. Dittrich

Erratum

Erratum to: Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases

J. Raber-Durlacher, N. Weijl, M. Abu Saris, B. de Koning, A. Zwinderman, S. Osanto

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine